ACE2 and COVID-19: Because multiple pharmacological drugs for hypertension target this pathway and affect either the availability or expression level of ACE2, we are presented with enormous complexity in the susceptibility, pathogenesis, and treatment of COVID-19 (Bosso et al., 2020).